COMPANY
MIP PHARMA GMBH
MIP PHARMA GMBH: marketing authorisation holder for Daptomycin, Vancomycin, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Daptomycin | DAPTOMYCIN 350 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 26928/0017, Authorised Regulator MHRA |
|---|---|
| Daptomycin | DAPTOMYCIN 500 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 26928/0018, Authorised Regulator MHRA |
| Vancomycin | VANCOMYCIN 1000 MG POWDER FOR SOLUTION FOR INFUSION, PL 26928/0016, Authorised Regulator MHRA |
| Vancomycin | VANCOMYCIN 500 MG POWDER FOR SOLUTION FOR INFUSION, PL 26928/0015, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.